DCC3616 |
Nepetin [520-11-6] |
Natural inducer of autophagy and apoptosis, inhibiting glutamate overexcitation and upregulation of the Wnt/β-catenin signaling pathway |
|
DCC3617 |
Neq0502 |
Novel AR inhibitor, being selective for the testosterone stimulated AR-dependent prostate cancer cell |
|
DCC3618 |
neq135 |
The first potent NAD-driven small molecular inhibitor of TcGAPDH (Trypanosoma cruzi glyceraldehyde 3-phosphate dehydrogenase) |
|
DCC3619 |
nequimed176 |
Novel non-peptidic, non-covalent cruzain inhibitor |
|
DCC3620 |
Nesiritide Acetate |
Human B-type natriuretic peptide, facilitating cardiovascular fluid homeostasis through counterregulation of the renin-angiotensin-aldosterone system, stimulating cyclic guanosine monophosphate, leading to smooth muscle cell relaxation |
|
DCC3621 |
Nestifylline |
Anti-inflammatory, antibronchospastic agent |
|
DCC3622 |
Netarsudil Mesylate |
Novel dual Rho Kinase and norepinephrine transporter (ROCK/NET) inhibitor |
|
DCC3623 |
Net-c343 |
Novel fluorescent RXR antagonist |
|
DCC3624 |
N-ethylglycine |
Lidocaine metabolite, showing antinociceptive effects, inhibiting GlyT1-mediated glycine uptake |
|
DCC3625 |
N-ethylmaleimide |
Modulator of the T1007 site, resulting in rapid activation of this transporter and potentiating KCC2 activity |
|
DCC3626 |
Neu321 |
Ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth |
|
DCC3627 |
Neu-4854 |
Novel potent Trypanosoma brucei Inhibitor |
|
DCC3628 |
Neu617 |
Novel inhibitor of the growth of protozoan parasites, against T. brucei bloodstream proliferation |
|
DCC3629 |
Neu-730 |
Novel inhibitor of TbrPDEB1, showing modest inhibition of T. brucei proliferation |
|
DCC3630 |
Neurodazole |
Novel neurogenic inducer for converting pluripotent P19 cells into electrophysiologically active neurons |
|
DCC3631 |
Neuroprotectant-7 |
Novel neuroprotectant for Alzheimers disease, showing significant neuroprotection and antioxidative properties, crossing the blood-brain barrier (BBB) |
|
DCC3632 |
Neurotensin(8-13) |
The neurotensin active fragment, eliciting behavioral responses typical of clinically used antipsychotic drugs when administered directly to the brain |
|
DCC3633 |
Nexturastat A-crbn-12d |
Novel potent HDAC6 degrader with promising antiproliferation activity in multiple myeloma (MM) cells |
|
DCC3634 |
Nfat-133 |
Inhibitor of NFAT-mediated transcription, leading to the suppression of interleukin-2 expression and T cell proliferation, showing immunosuppressive, antidiabetic, and antitrypanosomal activities |
|
DCC3635 |
Nf-kappab Inhibitor-2 |
First-in-class inhibitor of NF-κB signaling pathway by preventing the maturation of a rate-limiting multiprotein complex necessary for IKK activation |
|
DCC3636 |
N-formyl-met-phe |
Neutrophil Dysfunction Test Peptide |
|
DCC3637 |
Nfu1827 |
Novel inhibitor of human cytomegalovirus (HCMV) infection |
|
DCC3638 |
Ngd 98-2 |
New generation, topology 2 selective orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist |
|
DCC3639 |
Ngd-8243 |
Novel TRPV1 Antagonist |
|
DCC3640 |
Ngd9002 |
New generation, topology 2 selective corticotropin releasing factor-1 (CRF-1) receptor antagonist |
|
DCC3641 |
Ngp1-01 |
Brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels, acting as chemosensitizer and circumvent the resistance of the plasmodia parasite against chloroquine (CQ) by inhibiting the p-glycoprotein efflux pump and enabling th |
|
DCC3642 |
Nh2-bodipy |
Novel cell-permeant probe for the super-resolution imaging of the endoplasmic reticulum in live cells |
|
DCC3643 |
Nh2-nplh2 |
Novel luciferin analog, enabling both sensitive and highly resolved imaging in vivo |
|
DCC3644 |
Nh2-uamc1110 |
UAMC1110 Conjugate Linker |
|
DCC3645 |
Nhi-1j |
Selective Inhibitor of Human Lactate Dehydrogenase Isoform A (LDH-A) |
|